Fierce Medtech Names Exo a “Fierce 15” Company of 2023

Fierce Medtech Names Exo a “Fierce 15” Company of 2023. Exo receives honor for pioneering a simple and accessible medical imaging ecosystem for the healthcare industry

Exo receives honor for pioneering a simple and accessible medical imaging ecosystem for the healthcare industry.

Santa Clara, CA., March 4, 2024 — Exo, a medical imaging software and devices company, today announced that Fierce Medtech has named it as one of 2023’s “Fierce 15” medical technology companies. The annual special report, features the most innovative private medtech companies in the industry.

“We are thrilled at the news,” said Sandeep Akkaraju, Co-founder and CEO at Exo. “This award from Fierce Medtech demonstrates once again that Exo is at the forefront of healthcare innovation. We have built an entire point-of-care ultrasound (POCUS) ecosystem around the needs of caregivers to accelerate patient care, combining high-performance handheld ultrasound with artificial intelligence and customer-centric software so users can get to immediate answers right at the point of care.”

Exo’s mission is to get medical imaging into the hands of all caregivers to screen, diagnose and monitor chronic and acute conditions at the point of care, quantitatively, and reproducibly at a population scale. Exo was selected as a Fierce 15 company of 2023 because of how it’s combining hardware and software so both expert and minimally trained users can get fast, actionable insights for their patients. With the recent launch of Exo Iris™, Exo has wrapped together powerful ultrasound imaging, streamlined workflow software and real-time artificial intelligence (AI) to form an ecosystem that brings medical imaging to much-needed locations and populations, such as at the bedside, in an ambulance or in remote locations.

“Every year we celebrate a few of the most innovative toolmakers, whether they’re focused on helping clinicians reach, diagnose and treat the sick, or assisting the researchers chasing the next scientific and medical breakthroughs,” said Conor Hale, senior editor of Fierce Medtech. “These companies exemplify the ability of the medtech industry to turn cutting-edge ideas into meaningful outcomes and make them accessible on a large scale.”

Read the Fierce Medtech 15 special report here: https://www.fiercebiotech.com/special-reports/fierce-medtechs-fierce-15-2023

About Fierce MedTech

Fierce Medtech keeps biopharma executives, device developers, engineers, and researchers updated on the must-know news, trends and developments in medical technology. Top industry professionals rely on Fierce Medtech for an insider briefing on the day's top stories.

About Exo

Exo, a medical imaging software and device company, believes everyone around the world should have access to immediate medical answers at the point of care. The company is on a mission to trailblaze new care pathways and modernize the medical landscape through its high-performance ultrasound platform and artificial intelligence, delivering high-quality, affordable and easy-to-use medical imaging to all caregivers. Exo’s ecosystem provides caregivers with instant answers to make critical decisions at the point of care to improve patient outcomes. For more information, please visit exo.inc. Follow us at @exoeffect on X, LinkedIn, Facebook and Instagram.

Hannah Fairbanks